A Prospective Trial of Virtual Home Rehabilitation After Burn Injury
Launched by UNIVERSITY OF WASHINGTON · Mar 22, 2018
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
This is a prospective, randomized controlled trial (PRCT) involving 50 adult burn survivors. This study tests the efficacy of a technology-assisted rehabilitation program against current standard of home therapy. There are two study groups for which subjects will be randomized: control and experimental.The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge. The experimental group receives treatment as usual, in addition to training and use of the Jintronix platform for 3 months after ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 18 years old (no upper age limit)
- • Ability to provide written, informed consent for study participation
- • Ability to read and understand English
- • Anticipated discharge to home environment
- * Home environment includes access to:
- • television (larger than 20 inches in diameter with High Definition Multimedia Interface input (HDMI)
- • internet and email address
- • telephone (cell phone or landline)
- Exclusion Criteria:
- • Age less than 18 years
- • Inability to provide written, informed consent for study participation
- • Inability to read or understand English
- • Delirium (as determined by the Delirium Observation Score test)
- • Near-fall event at time of screening
- • Pregnant women
- • Discharge to non-home environment (e.g., shelter, street, skilled nursing facility)
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Tam Pham, MD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials